Our editorial for the revealing systematic review by Roger Li Ashish M. Kamat, MD, MBBS @sgilbert1973 et al. Important work to be done in post-BCG #NMIBC trials to facilitate comparison among next generation of treatment options. @BrantInman Dominic Grimberg #blcsm x.com/EUplatinum/sta…

Multidisciplinary review of frailty assessments in bladder cancer sciencedirect.com/science/articl… Ankeet Shah Jeroen Molinger John Paul Wischmeyer MD Rajan T. Gupta MD Shelley McDonald @BrantInman

Thank you Amer. Urol. Assn. for the opportunity to present & for consideration of best poster! First step towards using novel neurotoxins in urology. #AUAVirtualExp #AUAVirtualSci Boston Children's

🚨 Smoking status is associated with lower NACh response rates and higher overall and cancer-specific mortality as well as recurrence after RC. ✅ Proper preoperative counseling, and tightened follow-up, have pivotal role. 👉🏼 doi.org/10.1097/ju.000…

Whoa!! The gut #microbiome switches mutant p53 from tumour-suppressive to oncogenic nature.com/articles/s4158… Molly Ingersoll @SITCancer Anirban Maitra

Our review of the GemRIS device, an exciting innovation in intravesical drug delivery Ankeet Shah @BrantInman

Curative Tx should be offered to pts with cN+ #bladdercancer (Even lower RP dz 👀 fig). In the absence of readily available biomarkers, preop CT (node size, #, morphology) can predict response. Sia Daneshmand, M.D. Dr. Hooman Djaladat USC Urology Rutgers Cancer Institute Society of Urologic Oncology Bladder Cancer Advocacy Network

Our oncologic surgeons at Duke Urology are looking forward to the SUO annual meeting. We are excited to discuss our fellowship program with interested resident applicants. DM me or Ankeet Shah to set up a meeting at SUO…